Welcome to the 9th webinar in the Vitaccess “Keeping it real” series. This webinar is in collaboration with Envision the Patient, part of the Envision Pharma Group.
During this webinar we will explore the role of patients in the design, delivery, and communication of real-world studies. In particular, we will focus on the value of the patient voice in publications of real-world evidence.
The presenters will discuss opportunities for patient co-authorship of peer-reviewed journal publications and extenders to optimize the reach and understanding of real-world data.
Vitaccess is an innovator in digital research and an established partner in real-world studies. Our holistic approach and in-house Vitaccess Real™ platform mean our real-world studies come in one full package that not only includes data collection from PROs, but also analytics and localization.
Envision the Patient is a team dedicated to optimizing patient engagement across the product lifecycle. With expertise in working with patients to inform medical strategy and co-create medical and healthcare communications, they are a trusted partner to global medical affairs teams.
Dr Catherine Bottomley, Chief Scientific Officer, Vitaccess
Catherine not only ensures that the data from our studies meet stakeholder requirements, but also that our research is conducted in the best interests of patients, and that the data we collect reflect the issues that matter most to them. Catherine is passionate about bringing patients’ voices to the center of healthcare research.
Dr Dawn Lobban, Global Lead, Patient Partnerships, Envision the Patient, part of the Envision Pharma Group
With a strong background in medical affairs, Dawn is passionate about patient involvement in medicine development. Through active participation in key working groups, including ISMPP (International Society for Medical Publication Professionals), MAPS (Medical Affairs Professional Society), and PFDM (Patients Focused Medicine Development), Dawn works hard to explore optimal ways to ensure effective patient engagement. Her research and opinions are published in a number of peer-reviewed publications.
Find out more about Envision Pharma Group